Clinical Trials Logo

Dysphonia clinical trials

View clinical trials related to Dysphonia.

Filter by:

NCT ID: NCT04764604 Completed - Dysphonia Clinical Trials

Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment

Start date: December 14, 2020
Phase: N/A
Study type: Interventional

A feasibility study to identify the immediate effect on the voices of patients with voice disorders (muscle tension dysphonia, vocal fold palsy or presbylaryngis) produced by exercising with Acapella Choice as a form of semioccluded vocal tract exercise (SOVTE).

NCT ID: NCT04729660 Completed - Dysphonia Clinical Trials

Efficacy of Kinesio Taping on Mutational Falsetto

Start date: July 31, 2020
Phase: N/A
Study type: Interventional

This study aimed to assess of efficacy of the kinesio-taping on male patients suffering from mutational falsetto

NCT ID: NCT04713033 Enrolling by invitation - Dysphonia Clinical Trials

Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice

Start date: September 9, 2021
Phase: N/A
Study type: Interventional

The long-term goal is to transform the diagnosis and treatment of dysphonia by elucidating cervical and cranial neuromuscular mechanisms underlying typical and disordered voicing. The overall objective of this application is to propose and evaluate a novel objective spectrotemporal diagnostic tool measuring functional cervical-cranial muscle network activity in typical and disordered speakers.The purpose of this study is to improve our understanding of how the vocal tract and the muscles of the larynx and the head work at baseline and after vocal fatigue.

NCT ID: NCT04710862 Recruiting - Clinical trials for Muscle Tension Dysphonia

The Effects of Respiratory Training on Voice

Start date: May 12, 2021
Phase: N/A
Study type: Interventional

Primary muscle tension dysphonia is a voice disorder that involves excessive and poorly coordinated muscle activity affecting multiple subsystems that are involved in speech production, in the absence of structural or neurologic abnormalities of the larynx. Primary muscle tension dysphonia (MTD) is one of the most common forms of voice disorders, accounting for at least 40% of patients seen in voice clinics. Perceptually the voice sounds hoarse and strained, with reduced loudness and pitch range, and people with MTD find speaking very effortful and fatiguing. The physiological abnormalities that characterize MTD are considered multifactorial, and include over-activity of muscles in and around the larynx, laryngeal constriction patterns, and abnormal speech breathing patterns. However, standard treatment approaches for MTD primarily address laryngeal function, including repositioning of laryngeal structures, reducing activity in the intrinsic and extrinsic laryngeal muscles, and altering vibratory patterns. Although voice improvement may follow these treatments, many people with MTD show recurrence of voice problems after only a few months, and some do not improve with treatment. These findings highlight the need for alternative treatments that address the respiratory contributions to MTD, which directly affect the phonatory system. The goal of this project is to compare the effects of two respiratory-based training conditions in people with MTD. A randomized group design will be implemented to determine the respiratory and acoustic effects of each condition. We will determine the effects of each condition immediately after and then 3 and 6 months after training completion to assess short- and long-term training effects. We propose that respiratory training will have a positive effect on related laryngeal behavior and voice. The proposed project has the potential to substantially advance the evidence-based treatment options for MTD, providing a vital step toward reducing the debilitating effects of this disorder.

NCT ID: NCT04650893 Recruiting - Dysphagia Clinical Trials

The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF

Start date: January 2, 2021
Phase: Phase 3
Study type: Interventional

This study is to assess the efficacy of intraoperative intravenous nonsteroidal anti-inflammatory drug (ketorolac) versus intravenous (dexamethosone) administration on dysphagia and dysphonia after ACDF.

NCT ID: NCT04648891 Completed - Spasmodic Dysphonia Clinical Trials

Spasmodic Dysphonia Pain

Start date: August 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This study aims to identify adjuvant methods to improve patient comfort during in-office laryngology procedures.

NCT ID: NCT04591769 Completed - Pain, Postoperative Clinical Trials

Tracheal Tube Cuff Shape and Pressure

Start date: November 5, 2020
Phase: N/A
Study type: Interventional

This is a randomized controlled trial focusing on the effect of different tracheal tube cuff shape; the tapered-shaped tracheal tube cuff versus the cylindrical-shaped tracheal cuff in anterior cervical spine surgery.

NCT ID: NCT04584658 Recruiting - Covid19 Clinical Trials

Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)

DYADS
Start date: September 15, 2020
Phase:
Study type: Observational

This study examines the presence, severity and natural history of dysphagia and dysphonia in the post-extubation and severely unwell COVID-19 patient.

NCT ID: NCT04421365 Recruiting - Laryngeal Dystonia Clinical Trials

Brain-Computer Interfaces in Laryngeal Dystonia

Start date: April 18, 2022
Phase: N/A
Study type: Interventional

The researchers will develop and evaluate the use of adaptive closed-loop brain-computer interface therapeutic intervention in laryngeal dystonia.

NCT ID: NCT04412694 Recruiting - Postoperative Pain Clinical Trials

The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients.

Dexa
Start date: July 1, 2020
Phase: Phase 4
Study type: Interventional

Glucocorticoids are well known for their analgesic, anti-inflammatory, immunomodulatory and anti-emetic effects. Recovery time after thyroid surgery may depend on several factors, such as postoperative pain, nausea and vomiting, postoperative sore throat, voice disorders and symptomatic hypocalcaemia (low serum calcium level). However, there is little information in the literature about the preventive use of glucocorticosteroids in patients undergoing thyroid surgery. The aim of the study is to evaluate the clinical impact of preoperative oral dexamethasone supplementation on the surgical outcome in patients with multinodular goiter undergoing total thyroidectomy. Patients will be assigned to the supplementation group and the placebo group. In the supplementation group 8mg of dexamethasone will be administered orally one hour before surgery. In the postoperative period, the frequency and intensity of pain, nausea, vomiting, sore throat and hoarseness will be assessed. The incidence of symptoms of hypocalcaemia will also be evaluted. Preoperative and postoperative levels of vitamin D, cytokines, acute phase proteins and substances related to calcium metabolism will be measured in the blood. Cytokines levels in drainage fluid will also be assessed. The main hypothesis of the study is that in patients with supplementation postoperative discomfort and decrease in serum calcium and parathormone level and hypocalcemic symptoms will be less severe and the levels of proinflammatory substances will be decreased.